Table 2. Reticulated platelets in... | American Society of Hematology

Table 2.

Reticulated platelets in HCV-negative dialysis patients without rhEPO replacement therapy

Group	No. subjects	Age (y)	Dialysis duration (y)	Platelet counts (×10⁹/L)	Absolute counts of reticulated platelets (×10⁹/L)	Serum TPO levels (pg/mL)
Control	33	46.1 ± 10.9	—	242.9 ± 38.4	20.4 ± 13.1	90.9 ± 45.8
HD patients	45	51.6 ± 14.9	11.5^* ± 6.31	191.5^*,^† ± 36.7	8.66^† ± 5.36	111.7^† ± 37.3
CAPD patients	30	45.9 ± 11.7	7.20 ± 5.31	222.3^† ± 40.0	10.1^† ± 4.78	183.5^†,^‡ ± 52.8

Group	No. subjects	Age (y)	Dialysis duration (y)	Platelet counts (×10⁹/L)	Absolute counts of reticulated platelets (×10⁹/L)	Serum TPO levels (pg/mL)
Control	33	46.1 ± 10.9	—	242.9 ± 38.4	20.4 ± 13.1	90.9 ± 45.8
HD patients	45	51.6 ± 14.9	11.5^* ± 6.31	191.5^*,^† ± 36.7	8.66^† ± 5.36	111.7^† ± 37.3
CAPD patients	30	45.9 ± 11.7	7.20 ± 5.31	222.3^† ± 40.0	10.1^† ± 4.78	183.5^†,^‡ ± 52.8

P < .01 vs CAPD;

P < .01 vs control;

P < .01 vs HD patients.

Data are shown as the mean ± SD.

Reticulated platelets were analyzed by TO staining and flow cytometry.

All experiments were conducted in triplicate.